Central Epidemic Command Center (CECC) head Victor Wang says the Food and Drug Administration (FDA) is expected to review an application for emergency use authorization (EUA) of the Pfizer-BioNTech second-generation coronavirus vaccine.
Local drug maker, Medigen, says it is seeking an Emergency Use Authorization (EUA) for its coronavirus vaccine candidate after its Phase II clinical trials showed promising results.